Active11670525Private limited companySouthall

CELLCHEM UK LIMITED

Significant control: Soumendranath Ghosh (25–50%), Cellchem Pharmaceuticals Inc (25–50%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Cellchem UK Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Cellchem UK Limited sell?

Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

CELLCHEM UK LIMITED is an active private limited company (company number 11670525) incorporated on 9 November 2018, registered in Southall. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 30 November 2025, showing net assets of −£5,373, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 14% on the prior period (−£4,698). Across the last 3 periods on record the net-asset trend is falling.

Peer position · net assets

By net assets it sits in the bottom quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).

02

Ownership and control

2 active · 1 other
  • Mr Soumendranath Ghosh
    Individual · since 10 November 2018
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Cellchem Pharmaceuticals Inc
    corporate entity, Canada · since 10 November 2018
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • persons with significant control statement · since 9 November 2018 · ceased 10 November 2018

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
9 November 20187 yrs ago
Next accounts due
30 August 2027in 310 days
Confirmation statement due
23 November 2026in 30 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
05

Financials

3 periods on record · latest ending 30 November 2025
Net assets
−£5,373
vs Nov 2024
Cash at bank
Not reported
Turnover
Not disclosed
Employees
0
vs Nov 2024
Net assets
−£5,373
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 November 2025−£5,373——£4,872——0
30 November 2024−£4,698——£4,197——0
30 November 2023−£4,048——£3,547——0
Current ratio0.02Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-5,373 at 30 November 2025
  • Current assets below creditors within one yearCurrent ratio 0.02
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 9 November 2018

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 310 days
  2. Confirmation statement duein 30 days
  3. Accounts period endNet liabilities £5,373 · micro accounts
  4. Accounts period endNet liabilities £4,698 · micro accounts
  5. Accounts period endNet liabilities £4,048 · micro accounts
  6. Incorporated
08

Similar companies in Greater London

Same activity (wholesale of pharmaceutical goods), closest in incorporation date
09

Reminders for CELLCHEM UK LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.